Sygnis

Sygnis P/B

The P/B (Price-to-Book Ratio) of Sygnis (SYG.WA) as of Nov 7, 2026 is 1.69. In the previous year, P/B (Price-to-Book Ratio) was 1.38 — a change of 22.92% (higher).

P/B

1.69

YoY

22.92%

Last updated:

P/B (Price-to-Book Ratio) of Sygnis is 2025 1.69 . P/B (Price-to-Book Ratio) of Sygnis was 2024 1.38 . It decreases by 22.92% higher compared to the previous year.

The Sygnis P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2017
38.64 PLN
Jan 1, 2018
45.21 PLN
Jan 1, 2020
45.30 PLN
Jan 1, 2021
1.41 PLN
Jan 1, 2022
1.48 PLN
Jan 1, 2023
1.25 PLN
Jan 1, 2024
1.38 PLN
Jan 1, 2025
1.69 PLN
The Sygnis P/B history
YEARP/BYoY
1.69+22.92%
1.38+10.29%
1.25-15.59%
1.48+4.85%
1.41-96.89%
45.30+0.20%
45.21+17.00%
38.64—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sygnis Stock analysis

What does Sygnis do? Sygnis SA generates revenue through its research and development services across four segments: Bioconvergence, Nanotechnology, Power Engineering, and New Incremental Technologies. Bioconvergence focuses on bioprinting organs to prevent transplant shortages and creating bionic models for drug testing. Nanotechnology applies photoelectron spectroscopy and atomic force microscopy solutions to consumer products. Power Engineering develops energy storage methods for renewable energy sources. New Incremental Technologies specializes in 3D printing solutions. The company collaborates with over 85 specialists including physicists, mechatronics, chemists, engineers, designers, and sociologists to execute multiple projects. Clients for Sygnis SA's services include organizations requiring advanced research in bioprinting, nanotechnology applications, energy storage, and 3D printing solutions. The firm serves sectors such as healthcare, technology, and renewable energy through its specialized R&D segments. Projects are executed by its team of 85 specialists working across the four business areas. Sygnis SA's revenue streams are derived from contracts with clients seeking innovative R&D in organ bioprinting, bionic drug testing models, photoelectron spectroscopy applications, energy storage systems, and 3D printing technologies. The company's business model relies on delivering specialized research services to clients across healthcare, technology, and renewable energy sectors through its four distinct R&D segments. Sygnis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sygnis stock

P/B (Price-to-Book Ratio) of Sygnis is 1.69 in 2025.

P/B (Price-to-Book Ratio) of Sygnis changed from 1.38 to 1.69, representing a 22.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Sygnis since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Sygnis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Sygnis

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Sygnis